EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
TELA Bio, Inc. (TELA) had EBITDA Margin of -47.77% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$69.30M |
|
$-37.84M |
|
$22.43M |
|
$46.87M |
|
$103.42M |
|
$-34.12M |
|
$-3.87M |
|
$-37.98M |
|
$-37.98M |
|
$-37.84M |
|
$-37.84M |
|
$-37.84M |
|
$-37.84M |
|
$-34.12M |
|
$-33.10M |
|
28.53M |
|
28.53M |
|
$-1.33 |
|
$-1.33 |
|
| Balance Sheet Financials | |
$78.07M |
|
$2.34M |
|
$8.50M |
|
$86.57M |
|
$15.60M |
|
$41.12M |
|
$42.51M |
|
$58.11M |
|
$28.46M |
|
$26.72M |
|
$28.46M |
|
39.40M |
|
| Cash Flow Statement Financials | |
$-41.59M |
|
$4.45M |
|
$43.06M |
|
$46.99M |
|
$52.94M |
|
$5.94M |
|
$4.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.01 |
|
-- |
|
-- |
|
0.59 |
|
1.45 |
|
67.63% |
|
-49.23% |
|
-49.23% |
|
|
EBITDA Margin |
-47.77% |
-54.81% |
|
-54.60% |
|
$-42.58M |
|
-- |
|
-- |
|
-- |
|
0.80 |
|
1.76 |
|
6.86 |
|
53.19 |
|
-132.97% |
|
-141.63% |
|
-43.71% |
|
-54.38% |
|
$0.72 |
|
$-1.49 |
|
$-1.46 |
|